Janoshik test report
BPC-157
10 mg
- Reported purity
- 99.982%
- Report batch
- TAM001
- Report number
- #234241
- Analysis date
Previous batches (0)
No earlier batch reports are published for BPC-157. The available report is batch TAM001, shown above.
Research standards
Evidence for Targeted Advanced Molecules
TAM Global presents research peptides with clear product identity, labelled strength, analytical information and evidence-focused quality review.
Product identity
Profiles identify the named product, strength, and research category without inferring a different formulation.
Purity in context
Premium Research Peptides - ≥99.6% purity. Bacteriostatic Water - 99.9% purity. The TAM Pen has no purity value.
Primary research
Mechanism and pathway language is grounded in primary scientific literature wherever the product identity supports a direct match.
Study-model clarity
Cellular, animal, and early-stage evidence is described as such, keeping research interest distinct from human outcomes.
Telehealth consultations & quality assurance
Book a product consultation with our specialist.
- Telehealth consultations
- Registered Chemist
- Supplier audit
We have visited and audited our supplier's manufacturing facility as part of our supplier quality assessment.
TAM Global's Quality Assurance and Product Specialist is a Registered Chemist with experience in pharmaceutical manufacturing, quality assurance and regulatory affairs. She has also successfully completed the CQI and IRCA ISO 9001:2015 Lead Auditor examination.
Her review covers supplier documentation, batch and lot information, analytical methods, product specifications and scientific website content. Where information is incomplete or unclear, it is identified for further verification.
Explore telehealth consultation options and book directly with the team at TAM Global Research. Our quality-assurance specialist separately supports questions about product specifications, Certificates of Analysis and research information.
Book telehealth with TAM Global Researchtamglobalresearch.comOpens in a new tabAvailable certificates
Download Janoshik certificates of analysis
Review the supplied Janoshik reports for the products below. Catalogue strengths are shown for reference; measured amounts and results relate to the sample identified in each report. The NAD+ report records 509.79 mg and is linked to the 500 mg listing. The Retatrutide report records 8.93 mg and is available from the 5 mg listing as a supplied sample report, not verification of the amount or purity of a 5 mg vial. Purity values below are the results printed in each report, rather than catalogue purity claims. Verify each report directly with Janoshik using its original QR-code link.
Janoshik test report
CJC-1295 no DAC
5 mg catalogue product
- Reported purity
- 99.403%
- Report batch
- TAM001
- Report number
- #234251
- Analysis date
Previous batches (0)
No earlier batch reports are published for CJC-1295 no DAC. The available report is batch TAM001, shown above.
Janoshik test report
Ipamorelin
10 mg
- Reported purity
- 99.730%
- Report batch
- TAM001
- Report number
- #234242
- Analysis date
Previous batches (0)
No earlier batch reports are published for Ipamorelin. The available report is batch TAM001, shown above.
Janoshik test report
KLOW
80 mg
- Reported purity
- Not reported
- Report batch
- TAM001
- Report number
- #234252
- Analysis date
Previous batches (0)
No earlier batch reports are published for KLOW. The available report is batch TAM001, shown above.
Janoshik test report
Melanotan II
10 mg
- Reported purity
- 99.639%
- Report batch
- TAM001
- Report number
- #234244
- Analysis date
Previous batches (0)
No earlier batch reports are published for Melanotan II. The available report is batch TAM001, shown above.
Janoshik test report
MOTS-c
40 mg
- Reported purity
- 99.603%
- Report batch
- TAM001
- Report number
- #234248
- Analysis date
Previous batches (0)
No earlier batch reports are published for MOTS-c. The available report is batch TAM001, shown above.
Janoshik test report
NAD+
500 mg catalogue product · tested sample: 509.79 mg
Supplied NAD+ report #234250 (batch TAM001) records a tested amount of 509.79 mg; purity is not reported. Confirm that the supplied batch matches your order.
- Reported purity
- Not reported
- Report batch
- TAM001
- Report number
- #234250
- Analysis date
Previous batches (0)
No earlier batch reports are published for NAD+. The available report is batch TAM001, shown above.
Janoshik test report
Retatrutide
5 mg catalogue product · tested sample: 8.93 mg
Supplied Retatrutide report #234246 (batch TAM001) records 8.93 mg and 99.845% purity for the tested sample. The measured amount differs from this 5 mg listing; this report does not verify the amount or purity of a 5 mg vial. Confirm applicable batch documentation with the team.
- Reported purity
- 99.845%
- Report batch
- TAM001
- Report number
- #234246
- Analysis date
Previous batches (0)
No earlier batch reports are published for Retatrutide. The available report is batch TAM001, shown above.
Janoshik test report
Selank
10 mg
- Reported purity
- 99.224%
- Report batch
- TAM001
- Report number
- #234249
- Analysis date
Previous batches (0)
No earlier batch reports are published for Selank. The available report is batch TAM001, shown above.
Janoshik test report
Tirzepatide
10 mg
- Reported purity
- 99.791%
- Report batch
- TAM001
- Report number
- #234245
- Analysis date
Previous batches (0)
No earlier batch reports are published for Tirzepatide. The available report is batch TAM001, shown above.